Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

 

Gainers

  • Incannex Healthcare (NASDAQ:IXHL) stock moved upwards by 92.3% to $44.04 during Tuesday's pre-market session. The market value of their outstanding shares is at $2.1 billion.
  • Better Therapeutics (NASDAQ:BTTX) shares moved upwards by 14.07% to $4.62. The company's market cap stands at $109.0 million.
  • Virpax Pharmaceuticals (NASDAQ:VRPX) shares rose 13.15% to $2.15. The market value of their outstanding shares is at $25.1 million.
  • Nuwellis (NASDAQ:NUWE) shares rose 12.94% to $0.96. The company's market cap stands at $10.1 million.
  • Gain Therapeutics (NASDAQ:GANX) shares rose 11.21% to $3.67. The market value of their outstanding shares is at $43.5 million.
  • BioSig Technologies (NASDAQ:BSGM) stock moved upwards by 9.99% to $1.21. The market value of their outstanding shares is at $42.7 million.
  •  

Losers

  • IDEAYA Biosciences (NASDAQ:IDYA) stock declined by 17.8% to $10.0 during Tuesday's pre-market session. The company's market cap stands at $384.9 million. As per the news, the Q4 earnings report came out today.
  • Natera (NASDAQ:NTRA) shares decreased by 13.02% to $31.22. The company's market cap stands at $2.9 billion.
  • 4d pharma (NASDAQ:LBPS) stock decreased by 11.95% to $3.98. The market value of their outstanding shares is at $89.6 million.
  • Adaptimmune Therapeutics (NASDAQ:ADAP) stock decreased by 9.27% to $1.65. The company's market cap stands at $257.9 million. The company's, Q4 earnings came out yesterday.
  • Pasithea Therapeutics (NASDAQ:KTTA) shares fell 8.34% to $1.1. The market value of their outstanding shares is at $24.0 million.
  • Unicycive Therapeutics (NASDAQ:UNCY) shares decreased by 5.99% to $1.1. The company's market cap stands at $16.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.